BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 34067929)

  • 1. Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.
    Romano V; Belviso I; Venuta A; Ruocco MR; Masone S; Aliotta F; Fiume G; Montagnani S; Avagliano A; Arcucci A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into Melanoma Fibroblast Populations and Therapeutic Strategy Perspectives: Friends or Foes?
    Avagliano A; Arcucci A
    Curr Med Chem; 2022; 29(40):6159-6168. PubMed ID: 35726413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture.
    Di Blasio S; van Wigcheren GF; Becker A; van Duffelen A; Gorris M; Verrijp K; Stefanini I; Bakker GJ; Bloemendal M; Halilovic A; Vasaturo A; Bakdash G; Hato SV; de Wilt JHW; Schalkwijk J; de Vries IJM; Textor JC; van den Bogaard EH; Tazzari M; Figdor CG
    Nat Commun; 2020 Jun; 11(1):2749. PubMed ID: 32488012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal reprogramming: A target for tumor therapy.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Dec; 239():117049. PubMed ID: 31730862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterotypic signaling between dermal fibroblasts and melanoma cells induces phenotypic plasticity and proteome rearrangement in malignant cells.
    Pessotti DS; Andrade-Silva D; Serrano SMT; Zelanis A
    Biochim Biophys Acta Proteins Proteom; 2020 Dec; 1868(12):140525. PubMed ID: 32866629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach.
    Kim E; Rebecca V; Fedorenko IV; Messina JL; Mathew R; Maria-Engler SS; Basanta D; Smalley KS; Anderson AR
    Cancer Res; 2013 Dec; 73(23):6874-85. PubMed ID: 24080279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma's connections to the tumour microenvironment.
    Brandner JM; Haass NK
    Pathology; 2013 Aug; 45(5):443-52. PubMed ID: 23851614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
    Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
    Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.
    Zhang W; Wang J; Liu C; Li Y; Sun C; Wu J; Wu Q
    J Transl Med; 2023 Nov; 21(1):827. PubMed ID: 37978384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts.
    Mezawa Y; Orimo A
    FEBS J; 2022 May; 289(9):2429-2447. PubMed ID: 33786982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironment‑driven resistance to B‑Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts.
    Kodet O; Dvořánková B; Bendlová B; Sýkorová V; Krajsová I; Štork J; Kučera J; Szabo P; Strnad H; Kolář M; Vlček Č; Smetana K; Lacina L
    Int J Mol Med; 2018 May; 41(5):2687-2703. PubMed ID: 29393387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
    Sorrentino C; Miele L; Porta A; Pinto A; Morello S
    Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of single-cell ferroptosis regulation in intercellular communication and skin cutaneous melanoma progression and immunotherapy.
    Song B; Peng Y; Zheng Y; Zhu Y; Liu W; Wang K; Cui Z; Song B
    Cancer Immunol Immunother; 2023 Nov; 72(11):3523-3541. PubMed ID: 37638981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts.
    Avagliano A; Ruocco MR; Nasso R; Aliotta F; Sanità G; Iaccarino A; Bellevicine C; Calì G; Fiume G; Masone S; Masullo M; Montagnani S; Arcucci A
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression.
    Calvani M; Pelon F; Comito G; Taddei ML; Moretti S; Innocenti S; Nassini R; Gerlini G; Borgognoni L; Bambi F; Giannoni E; Filippi L; Chiarugi P
    Oncotarget; 2015 Mar; 6(7):4615-32. PubMed ID: 25474135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.